Back to Insight Magazine

How brain tumour cancer is treated today

Brain tumour cancer treatment has evolved significantly, incorporating advanced therapies and personalized approaches. This article explores current standard treatments, recent breakthroughs, and emerging options, providing a comprehensive overview for patients and caregivers.​
7 minutes
|
April 29 2025
|
Brain
|
Brain cancer
Alessia Casali

Standard treatment approaches

The treatment of brain tumours typically involves a combination of therapies:​

  • Surgery: The primary approach for accessible tumours, aiming to remove as much of the tumour as possible.​
  • Radiation therapy: Utilizes high-energy beams to destroy cancer cells, often following surgery.​
  • Chemotherapy: Employs drugs to kill cancer cells or stop their growth, used alone or in conjunction with other treatments.​

These treatments are tailored based on tumour type, location, and patient health.​

Recent advancements in treatment

Innovations in medical research have led to new therapies offering hope for improved outcomes:​

  • Targeted therapies: Drugs like tovorafenib (Ojemda) have been approved for treating specific genetic mutations in pediatric low-grade gliomas, offering a more personalized approach.​
  • Immunotherapy: Emerging treatments, such as the use of re-engineered poliovirus (PVSRIPO), are being explored to stimulate the immune system to attack glioblastoma cells.​
  • Nanotechnology: Researchers are developing nanoparticle-based drug delivery systems capable of crossing the blood-brain barrier, potentially enhancing treatment efficacy.​
  • Medical devices: Devices like the Tumour Treating Fields (TTFields) cap emit electric fields to disrupt cancer cell division, offering a non-invasive treatment option.​

Personalized medicine and genetic profiling

Advancements in genetic profiling allow for treatments tailored to individual tumour characteristics:​

  • IDH mutations: Drugs like vorasidenib (Voranigo) target specific mutations in grade 2 gliomas, representing a shift towards more precise therapies.​
  • BRAF mutations: Tovorafenib has shown effectiveness in treating gliomas with BRAF gene alterations.​

These targeted treatments exemplify the move towards personalized medicine in oncology.​

Emerging therapies on the horizon

Research continues to explore novel treatments:​

  • Radiopharmaceuticals: Clinical trials are investigating the use of radioactive substances, such as rhenium-186, delivered directly to tumours via devices like the Ommaya reservoir.​
  • Artificial intelligence: AI is being utilized to predict tumour regrowth and assist in treatment planning, enhancing the precision of care.​
  • Medical cannabis: Studies suggest that medical cannabis may help manage symptoms and potentially influence cancer progression, though more research is needed.​

Considering future options: cryopreservation

Facing a diagnosis of brain cancer can be overwhelming, especially when treatment options are limited. In such cases, exploring future-oriented possibilities becomes essential.​

At Tomorrow.bio, we offer human cryopreservation—a process of preserving individuals at low temperatures after legal death, with the hope that future medical advancements may allow for revival and treatment. While not a cure, it represents an opportunity to bridge today's limitations and tomorrow's possibilities.​

We understand the emotional weight of a terminal diagnosis. Our team is here to provide information and support, helping you make informed decisions about your future.​

The latest insights on cryonics, delivered each monday morning.

Related articles

About Tomorrow.bio

At Tomorrow.bio, we are dedicated to advancing the science of cryopreservation with the goal of giving people a second chance at life. As Europe’s leading human cryopreservation provider, we focus on rapid, high-quality standby, stabilization, and storage of terminal patients—preserving them until future medical technologies may allow revival and treatment.​

Our mission is to make human cryopreservation a reliable and accessible option for everyone. We believe that no life should end because current medical capabilities fall short.​

Our vision is a future where death is optional—where people have the freedom to choose long-term preservation in the face of terminal illness or fatal injury, and to awaken when medicine has caught up.​

Interested in learning more or becoming a member?

📧 Contact us at: hello@tomorrow.bio

🌐 Visit our website: www.tomorrow.bio

🤝 Schedule a call with our team: Book a call